Home Cart Sign in  
Chemical Structure| 115103-54-3 Chemical Structure| 115103-54-3

Structure of Tiagabine
CAS No.: 115103-54-3

Chemical Structure| 115103-54-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tiagabine is an anti-convulsive medication and a selective gamma-aminobutyric acid (GABA) reuptake inhibitor.

Synonyms: TGB; NO328; Gabitril

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tiagabine

CAS No. :115103-54-3
Formula : C20H25NO2S2
M.W : 375.55
SMILES Code : O=C([C@H]1CN(CC/C=C(C2=C(C)C=CS2)/C3=C(C)C=CS3)CCC1)O
Synonyms :
TGB; NO328; Gabitril
MDL No. :MFCD00865317

Safety of Tiagabine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01381523 - Completed - -
NCT00552526 Epilepsy Ment... More >>al Retardation Less << Phase 4 Unknown December 2013 Norway ... More >> SSE, Nevrological dep. , Rikshospitalet University hospital Oslo, Norway Less <<
NCT02727101 Epilepsy Phase 4 Terminated(slow enrollment) - United States, Maryland ... More >> MidAtlantic Epilepsy and Sleep Center Bethesda, Maryland, United States, 20817 Less <<
NCT00404248 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 1 Phase 2 Completed - United States, Alabama ... More >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT00404248 - Completed - -
NCT00068770 Brain and Central Nervous Syst... More >>em Tumors Less << Phase 2 Terminated(EORTC trail showed ... More >>TMZ & RT conferred significant survivial in this population) Less << - United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Massachusetts Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114-2617 United States, North Carolina Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1030 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Less <<
NCT01390909 - Completed - -
NCT00068770 - Terminated(EORTC trail showed ... More >>TMZ & RT conferred significant survivial in this population) Less << - -
NCT01390909 - Completed - -
NCT01587339 - Completed - -
NCT00855738 Focal Epilepsy Phase 4 Completed - -
NCT00855738 - Completed - -
NCT00236054 Generalized Anxiety Disorder Phase 3 Completed - United States, California ... More >> Pacific Institute for Medical Research, Inc. Los Angeles, California, United States, 90024 Pharmacology Research Institute Newport Beach, California, United States, 92660 Affiliated Research Institute San Diego, California, United States, 92108 Health Quest Clinical Trials San Diego, California, United States, 92123 Pacific Clinical Research Medical Group Upland, California, United States, 91786 United States, Florida UF Behavioral Health Clinic Jacksonville, Florida, United States, 32257 Janus Center for Psychiatric Research West Palm Beach, Florida, United States, 33407 United States, Georgia Atlanta Institute of Medicine & Research - Atlanta Clinic Atlanta, Georgia, United States, 30328 United States, Illinois Cunningham Clinical Research, LLC Edwardsville, Illinois, United States, 62025 United States, Louisiana LSUHSC Anxiety and Mood Disorders Clinic New Orleans, Louisiana, United States, 70115 United States, Michigan Summit Research Network Farmington Hills, Michigan, United States, 48336 United States, New York Social Psychiatry Research Inst. Brooklyn, New York, United States, 11235 Eastside Comprehensive Medical Center New York, New York, United States, 10021 Medical and Behavioral Health Research, PC New York, New York, United States, 10023 United States, Ohio Hartford Research Group Ltd. Cincinnati, Ohio, United States, 45242 United States, Oregon Oregon Center for Clinical Investigations, Inc. Salem, Oregon, United States, 97301 United States, South Carolina South East Health Consultants, LLC Charleston, South Carolina, United States, 29407 United States, Washington Northwest Clinical Research Center Bellevue, Washington, United States, 98004 United States, Wisconsin Northbrooke Research Brown Deer, Wisconsin, United States, 53223 Less <<
NCT00218166 Cocaine-Related Disorders Phase 2 Completed - United States, Kentucky ... More >> University of Kentucky Medical Center Lexington, Kentucky, United States, 40536 0086 Less <<
NCT00236067 Generalized Anxiety Disorder Phase 3 Completed - -
NCT00179465 Schizophrenia Phase 3 Active, not recruiting September 2019 United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT00015132 Cocaine-Related Disorders Phase 2 Completed - United States, Ohio ... More >> Cincinnati MDRU Cincinnati, Ohio, United States, 45220 Less <<
NCT00236015 Anxiety Disorder Phase 3 Completed - -
NCT00208741 Social Anxiety Disorder Phase 4 Completed - United States, Georgia ... More >> Emory University School of Medicine Atlanta, Georgia, United States, 30329 United States, New York Hillside Hospital of the North Shore-Long Island Jewish Health System Long Island, New York, United States, 10032 Columbia/New York State Psychiatric Institute New York, New York, United States, 10032 Less <<
NCT00214994 Anxiety Disorders Phase 3 Completed - -
NCT00129298 Cocaine-Related Disorders ... More >> Opiate Dependence Less << Phase 2 Completed - -
NCT01904487 Alcoholism Phase 1 Completed - United States, Pennsylvania ... More >> University of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT02387710 Sleep Apnea, Obstructive Phase 2 Completed - United States, Massachusetts ... More >> Sleep Disorders Research Program Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00174850 Anxiety Sexua... More >>l Dysfunction Less << Phase 4 Completed - United States, New York ... More >> Psychiatry Dept. SUNY Upstate Medical University Syracuse, New York, United States, 13210 Less <<
NCT00233675 General Anxiety Disorder Phase 3 Completed - -
NCT00086255 Cocaine-Related Disorders Phase 2 Completed - United States, Massachusetts ... More >> Boston University Medical Center Boston, Massachusetts, United States, 02215 United States, Ohio Cincinnati VA Medical Center Cincinnati, Ohio, United States, 45220 Dayton VA Medical Center Dayton, Ohio, United States, 45428 United States, Texas University of Texas Hlth Sci Ctr Houston Houston, Texas, United States, 77030 Less <<
NCT02387710 - Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.66mL

0.53mL

0.27mL

13.31mL

2.66mL

1.33mL

26.63mL

5.33mL

2.66mL

References

 

Historical Records

Categories